Literature DB >> 22460462

Hydrogen sulfide-induced colonic mucosal cytoprotection involves T-type calcium channel-dependent neuronal excitation in rats.

M Matsunami1, S Kirishi, T Okui, A Kawabata.   

Abstract

Hydrogen sulfide (H(2)S) is generated from L-cysteine by certain enzymes including cystathionine-γ-lyase (CSE) and cystathionine-β-synthase (CBS), and causes excitation of nociceptors mainly via activation of Ca(v)3.2 T-type Ca(2+) channels in the peripheral tissue, facilitating somatic and colonic pain. Here, we investigated whether sensory nerves and Ca(v)3.2 are involved in the H(2)S-induced mucosal cytoprotection against 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis in rats. Colitis was evaluated 3 days after intracolonic (i.c.) TNBS in the rat. Phosphorylation of ERK in the spinal dorsal horn was detected by immunohistochemistry. Protein expression of Ca(v)3.2 in the dorsal root ganglia (DRG) and of CSE and CBS in the colon was determined by Western blotting. Repeated i.c. NaHS significantly suppressed the TNBS-induced colitis in rats, an effect prevented by ablation of sensory nerves with repeated administration of capsaicin. Repeated pretreatment with T-type Ca(2+) channel blockers including ethosuximide significantly reduced the protective effects of repeated i.c. NaHS in the rats with TNBS-induced colitis. A single i.c. administration of NaHS induced ethosuximide-sensitive prompt phosphorylation of ERK in the spinal dorsal horn at T13 and L6-S1 levesl in the rats 1 day or 3 days after TNBS treatment, but not in naive rats. Ca(v)3.2 protein was upregulated in DRG 1 day after i.c. TNBS in rats, while CSE, but not CBS, protein was downregulated in the colon. Our findings suggest that luminal H(2)S causes excitation of sensory nerves most probably by activating Ca(v)3.2 T-type Ca(2+) channels that are upregulated in the early stage of colitis, leading to colonic mucosal cytoprotection in rats.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22460462

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  12 in total

Review 1.  H2S and its role in redox signaling.

Authors:  Omer Kabil; Nicole Motl; Ruma Banerjee
Journal:  Biochim Biophys Acta       Date:  2014-01-11

2.  Thermal spring water drinking attenuates dextran-sulfate-sodium-induced colitis in mice.

Authors:  Gábor Pozsgai; Rita Benkó; Loránd Barthó; Katalin Horváth; Erika Pintér
Journal:  Inflammopharmacology       Date:  2015-01-06       Impact factor: 4.473

Review 3.  Hydrogen sulfide signaling in the gastrointestinal tract.

Authors:  David R Linden
Journal:  Antioxid Redox Signal       Date:  2013-05-19       Impact factor: 8.401

4.  The Role of H2S in the Gastrointestinal Tract and Microbiota.

Authors:  Ailin Xiao; Chuanyong Liu; Jingxin Li
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Phosphorylation of BK channels modulates the sensitivity to hydrogen sulfide (H2S).

Authors:  Guzel F Sitdikova; Roman Fuchs; Verena Kainz; Thomas M Weiger; Anton Hermann
Journal:  Front Physiol       Date:  2014-11-12       Impact factor: 4.566

6.  Neonatal Colonic Inflammation Increases Spinal Transmission and Cystathionine β-Synthetase Expression in Spinal Dorsal Horn of Rats with Visceral Hypersensitivity.

Authors:  Liting Zhao; Ying Xiao; Rui-Xia Weng; Xuelian Liu; Ping-An Zhang; Chuang-Ying Hu; Shan P Yu; Guang-Yin Xu
Journal:  Front Pharmacol       Date:  2017-10-04       Impact factor: 5.810

Review 7.  Postoperative Ileus and Postoperative Gastrointestinal Tract Dysfunction: Pathogenic Mechanisms and Novel Treatment Strategies Beyond Colorectal Enhanced Recovery After Surgery Protocols.

Authors:  Elvio Mazzotta; Egina Criseida Villalobos-Hernandez; Juan Fiorda-Diaz; Alan Harzman; Fievos L Christofi
Journal:  Front Pharmacol       Date:  2020-11-24       Impact factor: 5.810

8.  Enhanced synthesis and diminished degradation of hydrogen sulfide in experimental colitis: a site-specific, pro-resolution mechanism.

Authors:  Kyle L Flannigan; Jose G P Ferraz; Rui Wang; John L Wallace
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

9.  Assessment of the effectiveness and safety of ethosuximide in the treatment of abdominal pain related to irritable bowel syndrome - IBSET: protocol of a randomised, parallel, controlled, double-blind and multicentre trial.

Authors:  Nicolas Kerckhove; Julien Scanzi; Bruno Pereira; Denis Ardid; Michel Dapoigny
Journal:  BMJ Open       Date:  2017-07-18       Impact factor: 2.692

10.  Otoprotective effects of ethosuximide in NOD/LtJ mice with age-related hearing loss.

Authors:  Lu Sang; Tihua Zheng; Lingqian Min; Xiaolin Zhang; Xiufang Ma; Shami Entenman; Yipeng Su; Qingyin Zheng
Journal:  Int J Mol Med       Date:  2017-05-26       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.